PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Research output: Contribution to journal › Meeting Abstract › peer-review